Depression

The cause of depression

Unlike a broken arm, for example, depression cannot usually be traced to a single cause or trigger. Rather, it develops from the interaction of different influences. On the one hand, there are factors that lead to a predisposition, i.e. an increased risk of becoming depressed. Furthermore, there are current triggers that can cause the occurrence of depression in people with this predisposition. The question is often asked by those affected whether depression is a physique or a “mental” illness. As with a medal, one can look at two sides of every person suffering from depression: the psychosocial side and the neurobiological side.

The psychosocial situation includes the entire behavior, our life experiences and relationships with fellow human beings. Factors such as trauma or experiences of abuse in early life can increase the risk of developing depression later on. In medicine/psychology, terms such as vulnerability, susceptibility or acquired predisposition are used. Furthermore, triggers are often found, such as current loss experiences and/or overload situations. But also positive life changes (a vacation or a passed exam for example) can be triggers of a depressive episode.

In addition to psychosocial triggers, there are always physical causes for the development of depression, i.e. changes in the body and especially neurobiological changes in the brain. These include, for example, inherited factors that influence the risk of becoming ill. Current changes in stress hormones or imbalances in other neurotransmitters in the brain can act as triggers.

Depression

The cause of depression

Unlike a broken arm, for example, depression cannot usually be traced to a single cause or trigger. Rather, it develops from the interaction of different influences. On the one hand, there are factors that lead to a predisposition, i.e. an increased risk of becoming depressed. Furthermore, there are current triggers that can cause the occurrence of depression in people with this predisposition. The question is often asked by those affected whether depression is a physique or a “mental” illness. As with a medal, one can look at two sides of every person suffering from depression: the psychosocial side and the neurobiological side.

The psychosocial situation includes the entire behavior, our life experiences and relationships with fellow human beings. Factors such as trauma or experiences of abuse in early life can increase the risk of developing depression later on. In medicine/psychology, terms such as vulnerability, susceptibility or acquired predisposition are used. Furthermore, triggers are often found, such as current loss experiences and/or overload situations. But also positive life changes (a vacation or a passed exam for example) can be triggers of a depressive episode.

In addition to psychosocial triggers, there are always physical causes for the development of depression, i.e. changes in the body and especially neurobiological changes in the brain. These include, for example, inherited factors that influence the risk of becoming ill. Current changes in stress hormones or imbalances in other neurotransmitters in the brain can act as triggers.

Treatment of
depression

THC and other cannabinoids help the body fight against depression by reducing stress levels. CBD is especially effective in reducing anxiety and improving sleep.

Nature instead of antidepressants

Many drugs harm the body or have acute side effects. The reality is that the side effects of cannabis are usually very mild, yet cannabinoids can have a similarly strong effect on the patient.

Medical cannabis can be used to treat chronic, treatment-resistant depression and stabilize your emotions during a depressive episode.

The possible causes of depression are manifold and vary from person to person. They range from genetic predisposition and neurobiological disorders to certain developmental and personality factors that, when combined, can lead to depression.
People who suffer from depression have a lower tolerance for emotional and physical stress than healthy people. As a rule, a stressful single event triggers a depressive episode, such as a separation or the death of a close person. The cannabinoids THC and CBD from medical cannabis can help fight your depression. They have a mood-regulating effect and can quickly lighten your state of mind. Compared to classic antidepressants, medical cannabis can bring fewer side effects.
Cannabis as medicine has been used for many centuries to treat depression. Today, studies prove the antidepressant effects of cannabinoids from the hemp plant. In particular, the cannabinoid delta-9-tetrahydrocannabinol (THC) has been shown to be helpful. In some clinical studies, in which the effect of cannabis on various diseases was examined, the mood-lifting side effect of THC is repeatedly referred to.

In addition to the cannabinoid THC, the cannabinoid cannabidiol (CBD) from the hemp plant is also increasingly coming into the focus of science. A recent study from 2016 shows that CBD could be a fast-acting remedy for depression. In contrast, common antidepressants usually take up to four weeks before they have an effect. While cannabinoid medications and antidepressants cannot replace psychotherapy, cannabinoids THC and CBD could be a natural alternative without the severe side effects associated with antidepressants.

How Medical Marijuana Can Help Patients

DEPRESSION

Medical Cannabis for Depression: A Review of Supporting Studies

Introduction

Depression is a common mental health disorder affecting millions of people worldwide. Traditional treatments for depression include psychotherapy and pharmacotherapy, such as selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). However, not all patients respond to these treatments, leading researchers to explore alternative options, including medical cannabis. This review will discuss the evidence from several supporting studies that examine the potential benefits of medical cannabis as a treatment for depression.

Preclinical Evidence

Preclinical studies have provided valuable insights into the possible antidepressant effects of cannabis and its active components, such as tetrahydrocannabinol (THC) and cannabidiol (CBD). A review published in Frontiers in Pharmacology (2018) highlighted the potential antidepressant properties of CBD in animal models. The authors concluded that CBD showed promise as an antidepressant due to its ability to modulate serotonin levels and interact with various neurotransmitter systems implicated in depression. These preclinical findings lay the foundation for further investigation into the antidepressant potential of medical cannabis in humans.

Neuropathic Pain

Neuropathic pain, caused by damage or dysfunction of the nervous system, can be challenging to treat with traditional analgesics. A systematic review and meta-analysis published in the Journal of Pain (2015) assessed the efficacy of medical cannabis for neuropathic pain. The authors found moderate-quality evidence that cannabis-based medicines were effective in treating neuropathic pain, with a number needed to treat (NNT) of 5.6. This result indicates that, on average, one in every 5.6 patients treated with medical cannabis would experience a clinically significant reduction in neuropathic pain.

Observational Studies

Some observational studies suggest that medical cannabis may have a positive impact on depressive symptoms. A study published in the Journal of Affective Disorders (2018) examined the effects of medical cannabis use on self-reported symptoms of depression, anxiety, and stress. The authors found that patients reported a significant decrease in depression and anxiety symptoms following cannabis use, with the greatest reductions observed in patients with high baseline symptoms. However, it is important to note that observational studies cannot establish causality and may be subject to various biases, such as self-reporting and selection bias.

Clinical Trials

Randomized controlled trials (RCTs) provide the highest level of evidence for medical interventions. While there are limited RCTs examining the efficacy of medical cannabis for depression, some studies have evaluated the impact of cannabis-derived compounds on depressive symptoms in specific populations. A double-blind, placebo-controlled trial published in the American Journal of Psychiatry (2019) investigated the effects of CBD as an adjunctive treatment for patients with bipolar depression. The study found no significant differences between the CBD and placebo groups in terms of improvement in depressive symptoms, suggesting that CBD may not be effective for this specific population.

Safety and Side Effects

As with any medication, it is essential to consider the potential side effects and safety concerns associated with medical cannabis use for depression. Common side effects include dizziness, dry mouth, fatigue, and impaired cognitive function. Additionally, long-term cannabis use may be associated with an increased risk of dependence and worsening of depressive symptoms in some individuals. Therefore, healthcare providers must carefully evaluate the potential risks and benefits of medical cannabis for each patient and closely monitor treatment outcomes.

Conclusion

The current evidence on the efficacy of medical cannabis for depression is limited, with a small number of observational studies and clinical trials suggesting potential benefits. However, more rigorous research, including large-scale RCTs, is needed to draw definitive conclusions about the therapeutic potential of medical cannabis for depression. In the meantime, healthcare professionals should remain informed about the latest research developments and engage in open discussions with their patients about the potential risks and benefits of using medical cannabis for depression treatment.

DISCLAIMER

The information, including but not limited to, text, graphics, images and other material contained on this website are for intormational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.